Bioactive lipids and chronic inflammation: managing the fire within

V Chiurchiù, A Leuti, M Maccarrone - Frontiers in immunology, 2018 - frontiersin.org
Inflammation is an immune response that works as a contained fire that is pre-emptively
sparked as a defensive process during infections or upon any kind of tissue insult, and that …

Bioactive lipids, inflammation and chronic diseases

A Leuti, D Fazio, M Fava, A Piccoli, S Oddi… - Advanced Drug Delivery …, 2020 - Elsevier
Endogenous bioactive lipids are part of a complex network that modulates a plethora of
cellular and molecular processes involved in health and disease, of which inflammation …

Reviewing the significance of blood–brain barrier disruption in multiple sclerosis pathology and treatment

R Balasa, L Barcutean, O Mosora, D Manu - International journal of …, 2021 - mdpi.com
The disruption of blood–brain barrier (BBB) for multiple sclerosis (MS) pathogenesis has a
double effect: early on during the onset of the immune attack and later for the CNS self …

Ozanimod (RPC1063) is a potent sphingosine‐1‐phosphate receptor‐1 (S1P1) and receptor‐5 (S1P5) agonist with autoimmune disease‐modifying activity

FL Scott, B Clemons, J Brooks… - British journal of …, 2016 - Wiley Online Library
Background and Purpose Sphingosine1‐phosphate (S1P) receptors mediate multiple
events including lymphocyte trafficking, cardiac function, and endothelial barrier integrity …

Role of ceramide/sphingomyelin (SM) balance regulated through “SM cycle” in cancer

M Taniguchi, T Okazaki - Cellular signalling, 2021 - Elsevier
Sphingomyelin synthase (SMS), which comprises of two isozymes, SMS1 and SMS2, is the
only enzyme that generates sphingomyelin (SM) by transferring phosphocholine of …

Blood-brain barrier: more contributor to disruption of central nervous system homeostasis than victim in neurological disorders

M Xiao, ZJ Xiao, B Yang, Z Lan, F Fang - Frontiers in Neuroscience, 2020 - frontiersin.org
The blood-brain barrier (BBB) is a dynamic but solid shield in the cerebral microvascular
system. It plays a pivotal role in maintaining central nervous system (CNS) homeostasis by …

Fingolimod for the treatment of neurological diseases—state of play and future perspectives

R Brunkhorst, R Vutukuri, W Pfeilschifter - Frontiers in cellular …, 2014 - frontiersin.org
Sphingolipids are a fascinating class of signaling molecules derived from the membrane
lipid sphingomyelin. They show abundant expression in the brain. Complex sphingolipids …

Lipid metabolism in astrocytic structure and function

JAK Lee, B Hall, J Allsop, R Alqarni, SP Allen - Seminars in cell & …, 2021 - Elsevier
Astrocytes are the most abundant glial cell in the central nervous system and are involved in
multiple processes including metabolic homeostasis, blood brain barrier regulation and …

The direct effects of fingolimod in the central nervous system: implications for relapsing multiple sclerosis

SF Hunter, JD Bowen, AT Reder - CNS drugs, 2016 - Springer
Fingolimod, a structural analog of sphingosine derived from fungal metabolites, is a
functional antagonist of the G-protein-coupled sphingosine 1-phosphate (S1P) receptors …

Fingolimod may support neuroprotection via blockade of astrocyte nitric oxide

E Colombo, M Di Dario, E Capitolo… - Annals of …, 2014 - Wiley Online Library
Objective Although astrocytes participate in glial scar formation and tissue repair,
dysregulation of the NFκB pathway and of nitric oxide (NO) production in these glia cells …